-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

701. Experimental Transplantation: Basic Biology, Engraftment and Disease Activity: Poster II

Experimental Transplantation: Basic Biology, Engraftment and Disease Activity Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 6, 2015: 6:00 PM-8:00 PM
Hall A, Level 2 (Orange County Convention Center)

David H. McDermott, MD1, Paejonette Jacobs, PhD2*, Qian Liu, MD1*, Jiliang Gao, PhD1* and Philip M. Murphy, M.D.1*

1Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD
2Laboratory of Molecular Immunology, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD

Aimee G Kim, MD1*, Jesse D Vrecenak, MD2*, Linda Eissenberg3*, John F. DiPersio, MD, PhD3, Alan W Flake, MD2 and William H Peranteau, MD4

1Center for Fetal Research, The Children's Hospital of Philadelphia, Philadelphia, PA
2Department of General Surgery and The Center for Fetal Research, The Children's Hospital of Philadelphia, Philadelphia, PA
3Department of Medicine, Division of Oncology, Washington University School of Medicine, Saint Louis, MO
4Division of Pediatric General, Thoracic and Fetal Surgery and The Center for Fetal Research, The Children's Hospital of Philadelphia, Philadelphia, PA

Lindsay Nicholson, PhD1*, Emily Mavin, PhD1*, Lynne Minto2*, Julie Irving, PhD2, Anne Dickinson, PhD1* and Xiao-Nong Wang, MBBS, PhD1*

1Haematological Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom
2Northern Institute for Cancer Research, Newcastle upon Tyne, United Kingdom

Maria Rosa Lidonnici, PhD1,2*, Annamaria Aprile1,3*, Marta Frittoli, MD1,2*, Giacomo Mandelli, PhD1*, Ylenia Paleari, PhD1,2*, Bernhard Gentner, MD1,2,4*, Laura Bellio, MD5*, Elena Cassinerio, MD6*, Laura Zanaboni, MD6*, Maria Domenica Cappellini, MD6, Fabio Ciceri, MD4*, Sarah Marktel, MD7* and Giuliana Ferrari, PhD1,2

1San Raffaele-Telethon Institute for Gene Therapy (TIGET), Milan, Italy
2Università Vita-Salute San Raffaele, Milan, Italy
3Università degli Studi di Roma di Tor Vergata, Rome, Italy
4Hematology and Bone Marrow Transplantation Unit, Division of Regenerative Medicine, Stem Cells and Gene Therapy, San Raffaele Scientific Institute, Milan, Italy
5Immunohematology and Transfusion Medicine Unit, San Raffaele Scientific Institute, Milan, Italy
6Università di Milano, Ca Granda Foundation IRCCS, Milan, Italy
7Hematology and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute, Milan, Italy

Beverly SI Strong, PhD, Amanda E Lee, MD*, Tess J Newkold*, Lucas E Turner* and Aimen F Shaaban, MD

Center for Fetal Cellular and Molecular Therapy, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH

Takashi Ishida, M.D.1,2*, Satoshi Takahashi, M.D., Ph.D.3, Chen-Yi Lai, Ph.D.1*, Masaaki Higashihara, M.D., Ph.D.4, Hiromitsu Nakauchi, MD, PhD5 and Makoto Otsu, M.D., Ph.D.1

1Division of Stem Cell Processing / Stem Cell Bank, Center for Stem Cell Biology and Regenerative Medicine, Institute of Medical Science, University of Tokyo, Tokyo, Japan
2Department of Hematology, Kitasato University, Graduate School of Medical Science, Sagamihara, Japan
3Division of Molecular Therapy, Advanced Clinical Research Center, Institute of Medical Sciece, Univ. of Tokyo, Tokyo, Japan
4Department of Hematology, Kitasato Univ. School of Med., Sagamihara, Japan
5Division of Stem Cell Therapy, Center for Stem Cell Biology and Regenerative Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan

Julius C Fischer1*, Michael Bscheider, MD2*, Gabriel Eisenkolb1*, Alexander Wintges3*, Caroline A Lindemans, MD, PhD4*, Simon Heidegger, MD1*, Sebastien Monette, MD5*, Marco Calafiore6*, Kori A. Porosnicu Rodriguez6*, Sophie Lieberman6*, Chen Liu, MD, PhD7*, Christian Peschel8, Melissa Docampo6*, Enrico Velardi, PhD9*, Robert R. Jenq, MD10*, Alan M Hanash, MD, PhD10, Jarrod A Dudakov, PhD6, Tobias Haas, MD11*, Marcel van den Brink, MD, PhD10 and Hendrik Poeck, MD1*

1III. Medizinische Klinik, Klinikum rechts der Isar, Technische Universität München, München, Germany
2Laboratory of Immunology and Vascular Biology, Department of Pathology, Stanford University School of Medicine, Stanford, California, USA, Stanford, CA
3III. Medizinische Klinik, Klinikum rechts der Isar, Technische Universität München, München, Germany
4Pediatric Bone Marrow Transplantation Program, University Medical Center Utrecht, Utrecht, Netherlands
5Tri-Institutional Laboratory of Comparative Pathology, Memorial Sloan Kettering Cancer Center, New York, NY
6Department of Immunology, Memorial Sloan Kettering Cancer Center, New York, NY
7Department of Pathology, University of Florida, Gainesville, FL
8III. Medizinische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universität München, Munich, Germany
9Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY
10Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY
11III. Medizinische Klinik, Klinikum rechts der Isar, Technical University Munich, Munich, Germany

*signifies non-member of ASH